Author

Abigail Rullo

Loyola University ChicagoORCID 0009-0001-8979-6855Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

An ZhangiD· 1 shared Brenna FlowersiD· 1 shared David Lee WilliamsiD· 1 shared Francesco AngelucciiD· 1 shared Irida KastratiiD· 1 shared Keacha Chang· 1 shared Luke N. M. HardingiD· 1 shared Maurizio BocchettaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

An ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyRedox BiologyPeer-reviewedDec 20, 2025

Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy.

Abigail Rullo, Brenna Flowers, Keacha Chang…·Irida Kastrati

This study identifies non-covalent TXNRD inhibitors that block TNBC cell proliferation by depleting deoxynucleotides and inhibiting ribonucleotide reductase, challenging the pro-oxidant mechanism paradigm.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky